Construction of a differentiated human hepatocyte cell line expressing the herpes simplex virus-thymidine kinase gene

Naoya Kobayashi, Masahiro Miyazaki, Karen A. Westerman, Hirofumi Noguchi, Masakiyo Sakaguchi, Toshinori Totsugawa, Takamasa Watanabe, Toshihisa Matsumura, Toshiyoshi Fujiwara, Philippe Leboulch, Noriaki Tanaka, Masayoshi Namba

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Transient support using a hybrid artificial liver (HAL) device is a promising treatment for the patients with acute liver failure. Primary human hepatocytes are an ideal source for HAL therapy; however, the number of human livers available for hepatocyte isolation is limited by competition for use in whole organ transplantation. To overcome this problem, we previously established a highly differentiated human fetal hepatocyte cell line OUMS-29. Considering the potential risk when using these genetically engineered cells in humans, additional safeguards should be added to make the cells more clinically useful. In this work, the herpes simplex virus thymidine kinase (HSVtk) gene was retrovirally introduced into OUMS-29 cells. One of the HSVtk-expressed clones, OUMS-29/thymidine kinase (TK), grew in chemically defined serum free medium and expressed the genes of albumin, asialoglycoprotein receptor, glutamine synthetase, glutathione-S-transferase π, and blood coagulation factor X. In vitro sensitivity of the cells to ganciclovir was evaluated. Intrasplenic transplantation of 50 × 106 OUMS-29/TK cells prolonged the survival of 90% hepatectomized rats compared with medium injection alone (control). In the present study, we have established highly differentiated immortalized human hepatocytes with tight regulation. The cells may be clinically useful for HAL treatment.

Original languageEnglish
Pages (from-to)476-480
Number of pages5
JournalASAIO Journal
Volume47
Issue number5
Publication statusPublished - 2001

Fingerprint

Thymidine Kinase
Simplexvirus
Viruses
Liver
Hepatocytes
Artificial Liver
Genes
Cells
Cell Line
Albumin Receptors
Asialoglycoprotein Receptor
Transplantation (surgical)
Factor X
Glutamate-Ammonia Ligase
Ganciclovir
Acute Liver Failure
Serum-Free Culture Media
Organ Transplantation
Coagulation
Glutathione Transferase

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering

Cite this

Kobayashi, N., Miyazaki, M., Westerman, K. A., Noguchi, H., Sakaguchi, M., Totsugawa, T., ... Namba, M. (2001). Construction of a differentiated human hepatocyte cell line expressing the herpes simplex virus-thymidine kinase gene. ASAIO Journal, 47(5), 476-480.

Construction of a differentiated human hepatocyte cell line expressing the herpes simplex virus-thymidine kinase gene. / Kobayashi, Naoya; Miyazaki, Masahiro; Westerman, Karen A.; Noguchi, Hirofumi; Sakaguchi, Masakiyo; Totsugawa, Toshinori; Watanabe, Takamasa; Matsumura, Toshihisa; Fujiwara, Toshiyoshi; Leboulch, Philippe; Tanaka, Noriaki; Namba, Masayoshi.

In: ASAIO Journal, Vol. 47, No. 5, 2001, p. 476-480.

Research output: Contribution to journalArticle

Kobayashi, N, Miyazaki, M, Westerman, KA, Noguchi, H, Sakaguchi, M, Totsugawa, T, Watanabe, T, Matsumura, T, Fujiwara, T, Leboulch, P, Tanaka, N & Namba, M 2001, 'Construction of a differentiated human hepatocyte cell line expressing the herpes simplex virus-thymidine kinase gene', ASAIO Journal, vol. 47, no. 5, pp. 476-480.
Kobayashi, Naoya ; Miyazaki, Masahiro ; Westerman, Karen A. ; Noguchi, Hirofumi ; Sakaguchi, Masakiyo ; Totsugawa, Toshinori ; Watanabe, Takamasa ; Matsumura, Toshihisa ; Fujiwara, Toshiyoshi ; Leboulch, Philippe ; Tanaka, Noriaki ; Namba, Masayoshi. / Construction of a differentiated human hepatocyte cell line expressing the herpes simplex virus-thymidine kinase gene. In: ASAIO Journal. 2001 ; Vol. 47, No. 5. pp. 476-480.
@article{d882ee502ef34e7abbc59d0bcc8339ed,
title = "Construction of a differentiated human hepatocyte cell line expressing the herpes simplex virus-thymidine kinase gene",
abstract = "Transient support using a hybrid artificial liver (HAL) device is a promising treatment for the patients with acute liver failure. Primary human hepatocytes are an ideal source for HAL therapy; however, the number of human livers available for hepatocyte isolation is limited by competition for use in whole organ transplantation. To overcome this problem, we previously established a highly differentiated human fetal hepatocyte cell line OUMS-29. Considering the potential risk when using these genetically engineered cells in humans, additional safeguards should be added to make the cells more clinically useful. In this work, the herpes simplex virus thymidine kinase (HSVtk) gene was retrovirally introduced into OUMS-29 cells. One of the HSVtk-expressed clones, OUMS-29/thymidine kinase (TK), grew in chemically defined serum free medium and expressed the genes of albumin, asialoglycoprotein receptor, glutamine synthetase, glutathione-S-transferase π, and blood coagulation factor X. In vitro sensitivity of the cells to ganciclovir was evaluated. Intrasplenic transplantation of 50 × 106 OUMS-29/TK cells prolonged the survival of 90{\%} hepatectomized rats compared with medium injection alone (control). In the present study, we have established highly differentiated immortalized human hepatocytes with tight regulation. The cells may be clinically useful for HAL treatment.",
author = "Naoya Kobayashi and Masahiro Miyazaki and Westerman, {Karen A.} and Hirofumi Noguchi and Masakiyo Sakaguchi and Toshinori Totsugawa and Takamasa Watanabe and Toshihisa Matsumura and Toshiyoshi Fujiwara and Philippe Leboulch and Noriaki Tanaka and Masayoshi Namba",
year = "2001",
language = "English",
volume = "47",
pages = "476--480",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Construction of a differentiated human hepatocyte cell line expressing the herpes simplex virus-thymidine kinase gene

AU - Kobayashi, Naoya

AU - Miyazaki, Masahiro

AU - Westerman, Karen A.

AU - Noguchi, Hirofumi

AU - Sakaguchi, Masakiyo

AU - Totsugawa, Toshinori

AU - Watanabe, Takamasa

AU - Matsumura, Toshihisa

AU - Fujiwara, Toshiyoshi

AU - Leboulch, Philippe

AU - Tanaka, Noriaki

AU - Namba, Masayoshi

PY - 2001

Y1 - 2001

N2 - Transient support using a hybrid artificial liver (HAL) device is a promising treatment for the patients with acute liver failure. Primary human hepatocytes are an ideal source for HAL therapy; however, the number of human livers available for hepatocyte isolation is limited by competition for use in whole organ transplantation. To overcome this problem, we previously established a highly differentiated human fetal hepatocyte cell line OUMS-29. Considering the potential risk when using these genetically engineered cells in humans, additional safeguards should be added to make the cells more clinically useful. In this work, the herpes simplex virus thymidine kinase (HSVtk) gene was retrovirally introduced into OUMS-29 cells. One of the HSVtk-expressed clones, OUMS-29/thymidine kinase (TK), grew in chemically defined serum free medium and expressed the genes of albumin, asialoglycoprotein receptor, glutamine synthetase, glutathione-S-transferase π, and blood coagulation factor X. In vitro sensitivity of the cells to ganciclovir was evaluated. Intrasplenic transplantation of 50 × 106 OUMS-29/TK cells prolonged the survival of 90% hepatectomized rats compared with medium injection alone (control). In the present study, we have established highly differentiated immortalized human hepatocytes with tight regulation. The cells may be clinically useful for HAL treatment.

AB - Transient support using a hybrid artificial liver (HAL) device is a promising treatment for the patients with acute liver failure. Primary human hepatocytes are an ideal source for HAL therapy; however, the number of human livers available for hepatocyte isolation is limited by competition for use in whole organ transplantation. To overcome this problem, we previously established a highly differentiated human fetal hepatocyte cell line OUMS-29. Considering the potential risk when using these genetically engineered cells in humans, additional safeguards should be added to make the cells more clinically useful. In this work, the herpes simplex virus thymidine kinase (HSVtk) gene was retrovirally introduced into OUMS-29 cells. One of the HSVtk-expressed clones, OUMS-29/thymidine kinase (TK), grew in chemically defined serum free medium and expressed the genes of albumin, asialoglycoprotein receptor, glutamine synthetase, glutathione-S-transferase π, and blood coagulation factor X. In vitro sensitivity of the cells to ganciclovir was evaluated. Intrasplenic transplantation of 50 × 106 OUMS-29/TK cells prolonged the survival of 90% hepatectomized rats compared with medium injection alone (control). In the present study, we have established highly differentiated immortalized human hepatocytes with tight regulation. The cells may be clinically useful for HAL treatment.

UR - http://www.scopus.com/inward/record.url?scp=0034827166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034827166&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 476

EP - 480

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 5

ER -